[HTML][HTML] Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international …
KM Kunisaki, DE Niewoehner, G Collins… - The Lancet …, 2016 - thelancet.com
Background Observational data have been conflicted regarding the potential role of HIV
antiretroviral therapy (ART) as a causative factor for, or protective factor against, COPD. We …
antiretroviral therapy (ART) as a causative factor for, or protective factor against, COPD. We …
Urinary incontinence in chronic obstructive pulmonary disease: a common co-morbidity or a typical adverse effect?
S Battaglia, A Benfante, S Principe, L Basile… - Drugs & aging, 2019 - Springer
Urinary incontinence (UI) is defined as a loss of bladder control and is characterized by the
complaint of any involuntary leakage of urine. Evidence suggests that the prevalence of UI is …
complaint of any involuntary leakage of urine. Evidence suggests that the prevalence of UI is …
[HTML][HTML] COPD treatment–a conceptual review based on critical endpoints
Introduction Chronic obstructive pulmonary disease (COPD) is one of the main causes of
death and disability worldwide. Many treatment options are now available, but criteria for …
death and disability worldwide. Many treatment options are now available, but criteria for …
Long-term inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease, cardiovascular disease, and a recent hospitalised exacerbation …
A Papi, G Forini, M Maniscalco, E Bargagli… - European Journal of …, 2024 - Elsevier
Introduction Patients with chronic obstructive pulmonary disease (COPD) frequently have
cardiovascular comorbidities, increasing the risk of hospitalised COPD exacerbations (H …
cardiovascular comorbidities, increasing the risk of hospitalised COPD exacerbations (H …
The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients
M Malerba, M Nardin, A Radaeli… - Expert review of …, 2017 - Taylor & Francis
Introduction: Despite lack of knowledge in the field, several studies have underlined the role
of endothelium dysfunction and platelet activation as significant players in the development …
of endothelium dysfunction and platelet activation as significant players in the development …
[HTML][HTML] Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: the SUMMIT trial
C Crim, PMA Calverley, JA Anderson, AP Holmes… - Respiratory …, 2017 - Elsevier
Rationale Pneumonia risk with inhaled corticosteroid use in chronic obstructive pulmonary
disease (COPD) has not been thoroughly assessed in patients with moderate airflow …
disease (COPD) has not been thoroughly assessed in patients with moderate airflow …
[HTML][HTML] Effect of fracture risk in inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
S Peng, C Tan, L Du, Y Niu, X Liu, R Wang - BMC Pulmonary Medicine, 2023 - Springer
Background The fracture risk of patients with chronic obstructive pulmonary disease (COPD)
treated with inhaled corticosteroids is controversial. And some large-scale randomized …
treated with inhaled corticosteroids is controversial. And some large-scale randomized …
The long-term burden of COPD exacerbations during maintenance therapy and lung function decline
M Kerkhof, J Voorham, P Dorinsky… - … journal of chronic …, 2020 - Taylor & Francis
Introduction Early identification of preventable risk factors of COPD progression is important.
Whether exacerbations have a negative impact on disease progression is largely unknown …
Whether exacerbations have a negative impact on disease progression is largely unknown …
[Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care
JL Lopez-Campos, P Almagro, JT Gómez… - Archivos de …, 2022 - Elsevier
The current health care models described in GesEPOC indicate the best way to make a
correct diagnosis, the categorization of patients, the appropriate selection of the therapeutic …
correct diagnosis, the categorization of patients, the appropriate selection of the therapeutic …
Left ventricular volume and wall stress are linked to lung function impairment in COPD
P Alter, RA Jörres, H Watz, T Welte, S Gläser… - International journal of …, 2018 - Elsevier
Background Cardiovascular comorbidities are common in chronic obstructive pulmonary
disease (COPD). We examined the association between airflow limitation, hyperinflation and …
disease (COPD). We examined the association between airflow limitation, hyperinflation and …